China’s Next More Dangerous Bioweapon and How the U.S. is Helping Them Build It
U.S. virus research laboratories have become functioning subsidiaries of China’s biowarfare program.
Since the 1990s, U.S. universities and research institutions have been colonized by Chinese Communist Party (CCP) and People’s Liberation Army (PLA) scientists.
Through a process we call “scientific chain migration,” the first wave of CCP and PLA scientists, once established in laboratories in the U.S., invite their colleagues, who now have created a critical mass of CCP and PLA scientists in the U.S. collaborating with scientists in China linked to its biowarfare program, all supplemented with U.S. funding, skills and knowledge.
Leveraging its extensive, integrated military-civilian biowarfare program, Chinese People’s Liberation Army (PLA) scientists supervised the creation of the genetically-engineered COVID-19 coronavirus capable of multiple pathological effects beyond that of naturally-occurring respiratory viruses, one also pre-adapted for human infection.
According to Dr. Li-Meng Yan’s second report, the COVID-19 virus succeeded in fulfilling the criteria of an effective bioweapon as described in 2005 by PLA General Rui-fu Yang:
- It is significantly virulent and can cause large scale casualties.
- It is highly contagious and transmits easily, often through respiratory routes in the form of aerosols. The most dangerous scenario would be that it allows for human-to-human transmission.
- It is relatively resistant to environmental changes, can sustain transportation, and is capable of supporting targeted [military] release.
In 2010, General Rui-fu Yang together with three of his senior PLA colleagues Zhi-Kai Xu, Zhong-Tian Qi and Fu-Quan Hu wrote that the new era required a military microbiology strategy that “should strive to cultivate and bring up a team of scientific and technological talents with strong innovation ability” regarding “pathogenic substances, pathogenic mechanisms and immune mechanisms of important pathogenic microorganisms” “including the construction and management of high-level biosafety laboratories” for research related to “biological warfare.”
They placed a special emphasis on flaviviruses and its envelope protein that “contains many single amino acids that affect viral neurovirulence and neuro-invasiveness.”
It is important to note that the envelope protein of the COVID-19 virus is believed to be related to its effect on the central nervous system, for example, the early loss of taste and smell. Perhaps, it was a test of concept for future bioweapons.
Flaviviruses are RNA viruses like coronavirus, but are far more dangerous attacking the central nervous system. They include yellow fever, Japanese encephalitis, West Nile, dengue fever and, finally, Zika virus, which is known for infecting pregnant women and causing severe brain damage in their babies.
Although flaviviruses are usually only transmitted by mosquitoes or other insects and are diseases not common in the United States, the PLA may be in the process of changing that situation.
The PLA has long had an extensive flavivirus military-civilian research program, which uses genetic engineering to create new combination viruses such as a combined Japanese encephalitis-Zika virus and conducts “gain of function” experiments, also using genetic engineering, making native Zika viruses more infectious.
The PLA has also shown a keen interest in and has conducted numerous studies on the American strain of Zika virus.
The types of experiments on flaviviruses now underway by the PLA are similar to those that were done for the creation of COVID-19.
PLA scientists have already begun studies on possible human-to human transmission of Zika virus via intranasal inoculation of non-human primates and the transmission between animals in close proximity.
Similar research on aerosol and contact transmission following intranasal infection of mice with Japanese Encephalitis Virus have been conducted by scientists in China.
Viral modifications could make a mosquito-transmitted flavivirus more deadly in a point attack or, using genetic engineering and other “gain of function” techniques, it would be a relatively small step to enhance their human-to-human infectivity.
China has made huge strides in flavivirus research by exploiting its multilayered, fused military-civilian biowarfare program of concurrent pathogen and vaccine development including the contributions made by numerous China-trained scientists operating in U.S. research centers.
Overall, China’s massive biowarfare program operates at three levels.
There is a core secret military level composed of military research centers and hospitals.
The second level includes all universities and “civilian” research centers, like the Wuhan Institute of Virology, because in China there is no difference between military and civilian research.
The fusion of civilian and military research was mandated by the Chinese Communist Party’s (CCP) Thirteenth Five Year Plan in 2016.
That second level allows the core secret military level to access knowledge and skills from the third level of China’s biowarfare program, international universities and research centers, particularly those in the U.S.
The organization of China’s flavivirus biowarfare program illustrates the fusion of military and civilian research and its links to U.S. personnel and resources as shown in the following images.
Level 1 – Core, secret military bioweapons program.